Articles

1. Psoralens + UV light

   Newsletter Article 11 February 2013 Pages: 7 - 7

2. Phytomenadione interaction see Warfarin

   Newsletter Article 11 February 2013 Pages: 7 - 7

3. Phenylpropanolamine

   Newsletter Article 11 February 2013 Pages: 7 - 7

4. Oxyphenisatin

   Newsletter Article 11 February 2013 Pages: 7 - 7

5. Oral contraceptives

   Newsletter Article 11 February 2013 Pages: 7 - 7

6. Oestrogen

   Newsletter Article 11 February 2013 Pages: 6 - 7

7. Nifedipine + atenolol

   Newsletter Article 11 February 2013 Pages: 6 - 6

8. Mianserin

   Newsletter Article 11 February 2013 Pages: 6 - 6

9. Lithium

   Newsletter Article 11 February 2013 Pages: 6 - 6

10. Isoniazid + Rifampicin

    Newsletter Article 11 February 2013 Pages: 5 - 6

11. Ibuprofen overdose

    Newsletter Article 11 February 2013 Pages: 5 - 5

12. Ibuprofen

    Newsletter Article 11 February 2013 Pages: 5 - 5

13. Doxycyline interaction see Warfarin

    Newsletter Article 11 February 2013 Pages: 5 - 5

14. Doxepin*

    Newsletter Article 11 February 2013 Pages: 5 - 5

15. Digoxin interaction see Rifampicin

    Newsletter Article 11 February 2013 Pages: 5 - 5

16. Clofibrate*

    Newsletter Article 11 February 2013 Pages: 5 - 5

17. Cisplatin

    Newsletter Article 11 February 2013 Pages: 5 - 5

18. Cimetidine*

    Newsletter Article 11 February 2013 Pages: 5 - 5

19. Cefamandole

    Newsletter Article 11 February 2013 Pages: 4 - 4

20. Carbamazepine*

    Newsletter Article 11 February 2013 Pages: 4 - 4

21. Captopril*

    Newsletter Article 11 February 2013 Pages: 4 - 4

22. Bromocriptine*

    Newsletter Article 11 February 2013 Pages: 3 - 4

23. Benoxaprofen

    Newsletter Article 11 February 2013 Pages: 3 - 3

24. BCG vaccination

    Newsletter Article 11 February 2013 Pages: 3 - 3

25. Atropine overdose

    Newsletter Article 11 February 2013 Pages: 3 - 3

26. Antacids

    Newsletter Article 11 February 2013 Pages: 3 - 3

27. Alprostadil

    Newsletter Article 11 February 2013 Pages: 3 - 3

28. Drug-induced disease

    Newsletter Article 11 February 2013 Pages: 2 - 2

29. Drug-related problems are a major cause of hospital admissions in UK

    Newsletter Article 11 February 2013 Pages: 2 - 2

30. Penicillin ester hepatotoxicity

    Newsletter Article 11 February 2013 Pages: 2 - 2

31. ‘Debendox’ and congenital malformations

    Newsletter Article 11 February 2013 Pages: 2 - 2

32. The risk of overt GI bleeding from aspirin appears to be low

    Newsletter Article 11 February 2013 Pages: 1 - 2

33. How do drugs affect sexual function?

    Newsletter Article 11 February 2013 Pages: 1 - 1

34. Side effects of propranolol

    Newsletter Article 04 February 2013 Pages: 11 - 12

35. Side effects of estrogens

    Newsletter Article 04 February 2013 Pages: 10 - 11

36. Effects of the anticholinergic activity of neuroleptics on withdrawal symptoms

    Newsletter Article 04 February 2013 Pages: 10 - 10

37. Carbamyl inhalation leads to airway irritation

    Newsletter Article 04 February 2013 Pages: 10 - 10

38. Chemical contamination from the environment

    Newsletter Article 04 February 2013 Pages: 9 - 10

39. Two cases of neuropathy after nitrous oxide abuse

    Newsletter Article 04 February 2013 Pages: 9 - 9

40. Abuse of anticholinergic drugs

    Newsletter Article 04 February 2013 Pages: 8 - 9

41. Ipratropium bromide

    Newsletter Article 04 February 2013 Pages: 8 - 8

42. Theophylline overdose

    Newsletter Article 04 February 2013 Pages: 7 - 7

43. Tamoxifen

    Newsletter Article 04 February 2013 Pages: 7 - 7

44. Sodium valproate

    Newsletter Article 04 February 2013 Pages: 7 - 7

45. Rosaramicin

    Newsletter Article 04 February 2013 Pages: 7 - 7

46. Psoralens + UV light

    Newsletter Article 04 February 2013 Pages: 7 - 7

47. Propylthiouracil

    Newsletter Article 04 February 2013 Pages: 6 - 7

48. Potassium chloride solutions

    Newsletter Article 04 February 2013 Pages: 6 - 6

49. Polygelatin

    Newsletter Article 04 February 2013 Pages: 6 - 6

50. Oxprenolol*

    Newsletter Article 04 February 2013 Pages: 6 - 6